Early Natalizumab Treatment for Multiple Sclerosis May Have Greater Benefit
Natalizumab treatment long after a multiple sclerosis diagnosis is associated with worse functional and brain outcomes compared with early initiation.
United States Sclerosis Partners Advancing Technology Commitment To Health Prescribing Program Health Solutions Multiple Sclerosis Multiple Sclerosis Partners Advancing Technology
Source: neurologyadvisor.com